Predictive value of serum interleukin-6 for neonatal encephalopathy outcomes
Journal of Neonatal-Perinatal Medicine · 2024
DOI: 10.3233/npm-230224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neonatal-Perinatal Medicine, 2024. Verfasst von Junichi Saito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Interleukin-6, Hypothermia, Induced, Hypoxia-Ischemia, Brain, Neurodevelopmental Disorders. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Serum interleukin-6 (IL-6) may predict adverse outcomes of neonatal encephalopathy (NE); however, limited data regarding the predictive utility of IL-6 during neurodevelopmental follow-up are available. We aimed to determine the utility of IL-6 for predicting adverse outcomes at 18 to 22 months of age.
Methods
Eighty-seven patients with NE who received therapeutic hypothermia were enrolled in this study. Serial serum IL-6 levels during the first 3 postnatal days were collected. Patients were classified into three groups: (1) death, (2) survival with moderate to severe neurodevelopmental disability (NDD) at 18–22 months of age, and (3) survival without NDD (favorable outcome). The predictive ability of IL-6 was determined by the area under the receiver-operating characteristic curve (AUC).
Results
Serial IL-6 data of 80 patients with NE were available and showed peak levels on postnatal day 1; these levels gradually decreased toward day 3. By 18–22 months of age, 13 and 17 patients died and experienced moderate to severe NDD without death, respectively. Fifty patients experienced favorable outcomes. Higher IL-6 levels on day 1 predicted the composite adverse outcome (including death and survival with NDD; n = 30; AUC, 0.648). Higher IL-6 levels on day 1 predicted death ( n = 13; AUC, 0.799), whereas higher IL-6 levels on day 1 predicted survival with NDD ( n = 17; AUC, 0.536).
Conclusions
The AUC of IL-6 that predicted survival with NDD was lower than the AUC of IL-6 that predicted death; therefore, IL-6 may have insufficient utility for predicting NDD without death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan.
- Department of Biostatistics, School of Medicine, Yokohama City University, Yokohama, Japan.
ORCID-Profile: Junichi Saito
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Saito, J., Shibasaki, J., Yamamoto, K., Fujita, M., & Toyoshima, K. (2024). Predictive value of serum interleukin-6 for neonatal encephalopathy outcomes. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.3233/npm-230224
Vancouver
Saito J, Shibasaki J, Yamamoto K, Fujita M, Toyoshima K. Predictive value of serum interleukin-6 for neonatal encephalopathy outcomes. Journal of Neonatal-Perinatal Medicine. 2024. doi:10.3233/npm-230224
BibTeX
@article{Saito2024,
author = {Saito, Junichi and Shibasaki, Jun and Yamamoto, Kouji and Fujita, Maya and Toyoshima, Katsuaki},
title = {Predictive value of serum interleukin-6 for neonatal encephalopathy outcomes},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2024},
doi = {10.3233/npm-230224}
}
EUVIMED